[REGN] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -43.80%
YoY- -3.53%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 2,169,500 2,048,400 1,933,700 1,711,800 1,927,800 1,663,496 1,608,022 22.03%
PBT 889,800 768,500 224,700 546,100 676,200 635,861 656,074 22.45%
Tax 97,800 98,900 31,600 85,000 -144,200 41,206 104,662 -4.40%
NP 792,000 669,600 193,100 461,100 820,400 594,655 551,412 27.21%
Tax Rate -10.99% -12.87% -14.06% -15.56% 21.33% -6.48% -15.95% -
Total Cost 1,377,500 1,378,800 1,740,600 1,250,700 1,107,400 1,068,841 1,056,610 19.28%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 36.51 32.69 9.99 26.94 42.56 35.75 34.29 4.25%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS 7.25 6.12 1.77 4.23 7.58 5.51 5.12 26.01%
EPS Diluted 6.93 5.86 1.68 3.99 7.15 5.17 4.82 27.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.